Friends of Cancer Research initiated a research partnership, inviting HRD assay developers to participate in two blinded analyses. In the first, 11 assay developers reported HRD status for the Cancer ...

For the nearly 20,000 women in the U.S. who receive an ovarian cancer diagnosis each year, artificial intelligence is emerging as a potentially life-saving tool. In a new study led by researchers at ...

Gynecological clear cell cancers (CCCs), very aggressive forms of ovarian and endometrial malignancies, respond poorly to chemotherapy. The low response rates underscore a significant clinical need to ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. But with promising early results from a phase 3 study in certain patients, the ...

Recently published preclinical data by City of Hope scientists shows the immunotherapy is effective. Advanced ovarian cancer patients are now being enrolled in a Phase 1 first-in-human trial. There ...

Colino is a contributor for TIME. Colino is a contributor for TIME. Ovarian cysts, which are small fluid-filled sacs that develop in or on the ovaries, are very common and are usually harmless. In ...

Around one in 10 women will develop ovarian cysts at some point during their lives, and while the prospect of a cyst growing on your ovaries could set off alarm bells, they aren’t something you need ...